Instil Bio, Inc. (TIL)
NASDAQ:TIL
Total Valuation
Instil Bio has a market cap or net worth of $54.46M. The enterprise value is $133.00M.
Market Cap$54.46M
Enterprise Value$133.00M
Share Statistics
Instil Bio has 6,781,976 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,781,976
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Instil Bio’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -26.58%.
Return on Equity (ROE)-0.63
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-26.58%
Return on Capital Employed (ROCE)-0.27
Revenue Per Employee0.00
Profits Per Employee-5.10M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Instil Bio is ―. Instil Bio’s PEG ratio is 0.17.
PE Ratio―
PS Ratio0.00
PB Ratio0.64
Price to Fair Value0.64
Price to FCF-2.00
Price to Operating Cash Flow-1.49
PEG Ratio0.17
Income Statement
In the last 12 months, Instil Bio had revenue of 0.00 and earned -71.37M in profits. Earnings per share was -10.70.
Revenue0.00
Gross Profit-534.00K
Operating Income-52.91M
Pretax Income-71.37M
Net Income-71.37M
EBITDA-52.37M
Earnings Per Share (EPS)-10.70
Cash Flow
In the last 12 months, operating cash flow was -36.62M and capital expenditures 0.00, giving a free cash flow of -36.62M billion.
Operating Cash Flow-36.62M
Free Cash Flow-36.62M
Free Cash Flow per Share-5.40
Dividends & Yields
Instil Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta5.22
52-Week Price Change-51.71%
50-Day Moving Average8.16
200-Day Moving Average16.71
Relative Strength Index (RSI)43.98
Average Volume (3m)39.27K
Important Dates
Instil Bio upcoming earnings date is May 7, 2026, Before Open (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
Instil Bio as a current ratio of 39.53, with Debt / Equity ratio of 74.81%
Current Ratio39.53
Quick Ratio39.53
Debt to Market Cap1.16
Net Debt to EBITDA-1.50
Interest Coverage Ratio-9.08
Taxes
In the past 12 months, Instil Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Instil Bio EV to EBITDA ratio is -2.90, with an EV/FCF ratio of -4.15.
EV to Sales0.00
EV to EBITDA-2.90
EV to Free Cash Flow-4.15
EV to Operating Cash Flow-4.15
Balance Sheet
Instil Bio has $76.13M in cash and marketable securities with $85.18M in debt, giving a net cash position of -$9.05M billion.
Cash & Marketable Securities$76.13M
Total Debt$85.18M
Net Cash-$9.05M
Net Cash Per Share-$1.33
Tangible Book Value Per Share$17.08
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Instil Bio is $7.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$7.00
Price Target Upside-10.14% Downside
Analyst ConsensusHold
Analyst Count2
Revenue Growth Forecast―
EPS Growth Forecast1.40%